Clinical Oncology - Issue 2/2024
Editorial
83
Reviews
88
Significance of aberrant DNA methylation for cancer diagnostics and therapy
T. Urban, P. Pokorná, O. Slabý
95
Prostate cancer invasion is promoted by the miR-96-5p-induced NDRG1 deficiency through NF-κB regulation
A. A. Soror, R. Eshagh, M. R. Fahim, A. Jamshidian, G. H. Monfared
102
Potential application of body fluids autofluorescence in the non-invasive diagnosis of endometrial cancer
M. Švecová, K. Fiedlerová, M. Mareková, K. Dubayová
Original Articles
110
Feasibility of implementation of the early tumor shrinkage as a potential predictive marker to daily clinical practice in patients with RAS wild type metastatic colorectal cancer, treated with cetuximab – a non-interventional observational study
J. Fínek, M. Vočka, J. Bauer, E. Kubala, K. Zycháčková, M. Šedivá, M. Gharibyar, I. Kocáková, E. Čmuchařová, M. Vaňková
118
Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation – single centre experience
M. Homolová, E. Bojtárová, M. Kováčová, K. Klučková, M. Suchánková, M. Kušíková, M. Mistrík, I. Shawkatová
126
Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer – the SENTRY clinical trial
P. Sorokin, M. Novozhilov, D. Utkin, Z. Abduragimova, I. Dudina, A. Nikiforchin, S. Kulikova
Case Reports
134
139
Carcinoid syndrome with right-sided valve involvement – a case report and review of the literature
I. Šimková, R. Aiglová, F. Koubek, J. Přeček, J. Látal, E. Buriánková, L. Quinn, L. Henzlová, M. Táborský, H. Švébišová, L. Tučková, B. Melichar
Reports from the literature
150
Various
152
Clinical Oncology
2024 Issue 2
Most read in this issue
- Significance of aberrant DNA methylation for cancer diagnostics and therapy
- Carcinoid syndrome with right-sided valve involvement – a case report and review of the literature
- Tailoring postoperative management through sentinel lymph node biopsy in low- and intermediate-risk endometrial cancer – the SENTRY clinical trial
- Factors influencing overall survival and GvHD development after allogeneic hematopoietic stem cell transplantation – single centre experience